Enter your search

THERAPEUTIC CLASSES

RARE DISEASES

DISCLAIMER: The content available on this site has been exclusively created for health professionals in order to keep them informed and bring them guidelines related to the proper use of medications. All information referring to products with medical prescription correspond to the guidelines approved by the corresponding health authority of each country in which Celnova Pharma operates. This content has no promotional objectives and is not intended to replace the recommendations of healthcare professionals. Celnova Pharma always suggests to appeal to a qualified healthcare professional for any questions about a particular medical condition.

PRODUCTS

TOBI®

Drug: tobramycin 300mg/5ml

Pharmaceutical form: ampoules

Presentation: case containing 56 ampoules

Product Availability: Argentina

Authorized indications: TOBI is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa.

Leaflet

 

TOBI PODHALER®

Drug: tobramycin 28mg

Pharmaceutical form: ampoules

Presentation: blister containing 224 units + 5 inhalers

Product Availability: Argentina

Authorized indications: TOBI Podhaler is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa.

Leaflet

ZOTEON®

Drug: tobramycin 300mg/5ml

Pharmaceutical form: ampoules

Presentation: case containing 56 ampoules

Product Availability: Chile

Authorized indications: ZOTEON is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa.

Leaflet

ZOTEON PODHALER®

Drug: tobramycin 28mg

Pharmaceutical form: ampoules

Presentation: blister containing 224 units + 5 inhalers

Product Availability: Chile

Authorized indications: ZOTEON Podhaler is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa.

Leaflet

DISEASE AREAS

TOBI® TOBI PODHALER®